Missouri — Federal authorities have seized approximately 73,000 units of illegal 7-hydroxymitragynine (7-OH) products—valued at about $1 million—from three Missouri firms, the U.S. Food and Drug Administration announced Wednesday. The U.S. Marshals Service carried out the seizures in coordination with the U.S. Department of Justice.
The targeted items included liquid shots, tablets, and other dietary supplement products containing concentrated 7-OH, a substance the FDA says poses significant risks because it binds to opioid receptors. Concentrated 7-OH cannot legally be added to dietary supplements or conventional foods and is considered adulterated under federal law. The FDA has not approved the ingredient for any medical use.
“This enforcement action is a strong step to protect Americans from the dangers of concentrated 7-OH products, which are potent opioids,” said FDA Commissioner Marty Makary, M.D., M.P.H. “We must be proactive and vigilant to address emerging threats to our communities and our kids.”
The operation was conducted with support from the Missouri Department of Health and Senior Services and builds on the FDA’s broader efforts to curb unlawful opioid-related products. Earlier this year, the agency recommended scheduling certain 7-OH products under the Controlled Substances Act and issued warning letters to companies selling 7-OH tablets, gummies, shots, and drink mixes. The FDA also notified health care professionals and warned consumers about the dangers of the substance.
“The rise in the use of concentrated 7-OH as an illegal ingredient in foods and dietary supplements is of particular concern,” said FDA Deputy Commissioner for Human Foods Kyle Diamantas, J.D. “Actions like those announced today put a marker down that our agency will not tolerate the use of this dangerous ingredient in foods and dietary supplements, especially in products that are accessible to our nation’s youth.”
Federal officials said the seizures underscore continued nationwide enforcement efforts and reminded manufacturers and distributors that all products must comply with federal safety and labeling standards.
